The financing comes after the company raised $30 million in August.
Iterative Scopes will focus on inflammatory bowel disease and colorectal cancer prevention with the development of its AI technology products and services.
The company offers an automated polyp detection tool, endoscopic scoring systems and a recruitment service for pharmaceutical companies to accelerate their IBD clinical trials.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
